1106 related articles for article (PubMed ID: 1628642)
21. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.
Yamazaki H; Gillam EM; Dong MS; Johnson WW; Guengerich FP; Shimada T
Arch Biochem Biophys; 1997 Jun; 342(2):329-37. PubMed ID: 9186495
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
[TBL] [Abstract][Full Text] [Related]
23. Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase.
Shet MS; Fisher CW; Holmans PL; Estabrook RW
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11748-52. PubMed ID: 8265621
[TBL] [Abstract][Full Text] [Related]
24. Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5.
Truan G; Cullin C; Reisdorf P; Urban P; Pompon D
Gene; 1993 Mar; 125(1):49-55. PubMed ID: 8449412
[TBL] [Abstract][Full Text] [Related]
25. Reconstitution of testosterone oxidation by purified rat cytochrome P450p (IIIA1).
Halvorson M; Greenway D; Eberhart D; Fitzgerald K; Parkinson A
Arch Biochem Biophys; 1990 Feb; 277(1):166-80. PubMed ID: 2106291
[TBL] [Abstract][Full Text] [Related]
26. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
27. Maximizing the expression of mammalian cytochrome P-450 monooxygenase activities in yeast cells.
Urban P; Cullin C; Pompon D
Biochimie; 1990; 72(6-7):463-72. PubMed ID: 2124149
[TBL] [Abstract][Full Text] [Related]
28. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
John GH; Hasler JA; He YA; Halpert JR
Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
[TBL] [Abstract][Full Text] [Related]
29. The high-level expression in Escherichia coli of the membrane-bound form of human and rat cytochrome b5 and studies on their mechanism of function.
Holmans PL; Shet MS; Martin-Wixtrom CA; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1994 Aug; 312(2):554-65. PubMed ID: 8037471
[TBL] [Abstract][Full Text] [Related]
30. Effects of human cytochrome b5 on CYP3A4 activity and stability in vivo.
Voice MW; Zhang Y; Wolf CR; Burchell B; Friedberg T
Arch Biochem Biophys; 1999 Jun; 366(1):116-24. PubMed ID: 10334871
[TBL] [Abstract][Full Text] [Related]
31. [Interaction of coumarin-hydroxylating cytochrome P-450coh from liver microsomes of mice induced by pyrazole with cytochrome b5].
Usanov SA; Honkakoski P; Lang M; Hanninen O
Biokhimiia; 1990 Jun; 55(6):995-1007. PubMed ID: 2119824
[TBL] [Abstract][Full Text] [Related]
32. Dynamic interactions of rabbit liver cytochromes P450IA2 and P450IIB4 with cytochrome b5 and NADPH-cytochrome P450 reductase in proteoliposomes.
Yamada M; Ohta Y; Bachmanova GI; Nishimoto Y; Archakov AI; Kawato S
Biochemistry; 1995 Aug; 34(32):10113-9. PubMed ID: 7640265
[TBL] [Abstract][Full Text] [Related]
33. Influence of glutathione on the catalytic activity of reconstituted cytochrome P450 3A4.
Kim BR; Kim DH
Biochem Biophys Res Commun; 1998 Jan; 242(1):209-12. PubMed ID: 9439637
[TBL] [Abstract][Full Text] [Related]
34. Electron shuttle between membrane-bound cytochrome P450 3A4 and b5 rules uncoupling mechanisms.
Perret A; Pompon D
Biochemistry; 1998 Aug; 37(33):11412-24. PubMed ID: 9708976
[TBL] [Abstract][Full Text] [Related]
35. Kinetic studies on a genetically engineered fused enzyme between rat cytochrome P4501A1 and yeast NADPH-P450 reductase.
Sakaki T; Kominami S; Takemori S; Ohkawa H; Akiyoshi-Shibata M; Yabusaki Y
Biochemistry; 1994 Apr; 33(16):4933-9. PubMed ID: 8161554
[TBL] [Abstract][Full Text] [Related]
36. Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.
Kaspera R; Naraharisetti SB; Evangelista EA; Marciante KD; Psaty BM; Totah RA
Biochem Pharmacol; 2011 Sep; 82(6):681-91. PubMed ID: 21726541
[TBL] [Abstract][Full Text] [Related]
37. Biodiversity of the P450 catalytic cycle: yeast cytochrome b5/NADH cytochrome b5 reductase complex efficiently drives the entire sterol 14-demethylation (CYP51) reaction.
Lamb DC; Kelly DE; Manning NJ; Kaderbhai MA; Kelly SL
FEBS Lett; 1999 Dec; 462(3):283-8. PubMed ID: 10622712
[TBL] [Abstract][Full Text] [Related]
38. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
[TBL] [Abstract][Full Text] [Related]
39. Influence of ionic strength on the P450 monooxygenase reaction and role of cytochrome b5 in the process.
Schenkman JB; Voznesensky AI; Jansson I
Arch Biochem Biophys; 1994 Oct; 314(1):234-41. PubMed ID: 7944401
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities.
Nakajima M; Tane K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
J Pharm Sci; 2002 Apr; 91(4):952-63. PubMed ID: 11948533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
